GeneOne Life Science, Inc. Logo

GeneOne Life Science, Inc.

Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.

011000 | KO

Overview

Corporate Details

ISIN(s):
KR7011000007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시

Description

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-31 00:00
주요사항보고서(자기전환사채매도결정)
Korean HTML 13.5 KB
2025-12-23 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 71.6 KB
2025-12-23 00:00
[기재정정]유상증자신주발행가액(안내공시)
Korean HTML 10.8 KB
2025-12-23 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 56.1 KB
2025-09-09 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 13.6 KB
2025-09-08 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 15.9 KB
2025-09-04 00:00
소액공모실적보고서
Korean HTML 25.7 KB
2025-09-04 00:00
유상증자또는주식관련사채등의발행결과(자율공시)
Korean HTML 7.5 KB
2025-09-03 00:00
유상증자또는주식관련사채등의청약결과(자율공시)
Korean HTML 7.1 KB
2025-08-29 00:00
소액공모공시서류(지분증권)
Korean HTML 1.9 MB
2025-08-29 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 49.7 KB
2025-08-29 00:00
유상증자신주발행가액(안내공시)
Korean HTML 4.2 KB
2025-08-22 00:00
주요사항보고서(유상증자결정)
Korean HTML 36.6 KB
2025-08-20 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.1 KB
2025-08-20 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 102.7 KB

Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeneOne Life Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD
Gubra A/S Logo
Biotech and CRO focused on peptide drugs for metabolic and fibrotic diseases.
Denmark
GUBRA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.